title: [The predictors of resistance to standard drug therapy in patients with hypertension and heart valve calcification].
abstract: The article presents results of their research to identify predictors of resistance to drug therapy in patients with essential hypertension (EH) and heart valves calcifications (HVC). Presented prognostic scale for selecting patients at high risk of resistance to drug therapy, through regression analysis. Designed the certain prognostic algorithm that will provide an opportunity practitioners to properly build tactics of treatment in patients with EH and HVC.
authors.forename: O V
authors.initials: OV
authors.lastname: Iuzvyshyna
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002114:Calcinosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004351:Drug Resistance; D000075222:Essential Hypertension; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006351:Heart Valves / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D018579:Patient Selection; D011379:Prognosis; D012044:Regression Analysis; D012307:Risk Factors
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors